Neurofibromatosis type 1: Future directions (where do we go from here?)

Luis F. Parada

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Two decades of modern molecular research on NF1 has provided unprecedented advances in our understanding of the neurofibromatosis type 1 gene, its protein neurofibromin, and its functions in the complexity that defines this disease. Despite this, the translation of this information into significant patient care enhancement has lagged. Today, the field is on the cusp of overturning this delay with the revolutionary breadth and depth of research findings that will in the near future culminate in the availability of meaningful new therapies for many aspects of NF1 disease. In so doing, the promise held by the cloning of the NF1 gene and its utilization in the development of physiologically relevant animal models will be fulfilled.

Original languageEnglish (US)
Title of host publicationNeurofibromatosis Type 1: Molecular and Cellular Biology
PublisherSpringer-Verlag Berlin Heidelberg
Pages691-698
Number of pages8
Volume9783642328640
ISBN (Print)9783642328640, 3642328636, 9783642328633
DOIs
Publication statusPublished - Aug 1 2012

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Parada, L. F. (2012). Neurofibromatosis type 1: Future directions (where do we go from here?). In Neurofibromatosis Type 1: Molecular and Cellular Biology (Vol. 9783642328640, pp. 691-698). Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/978-3-642-32864-0_44